Levetiracetam-induced interstitial nephritis in a patient with glioma

被引：13

作者：

Mahta, Ali ^{[1
]}

Kim, Ryan Y. ^{[1
]}

Kesari, Santosh ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Neurosci, Moores Canc Ctr, La Jolla, CA 92093 USA

来源：

JOURNAL OF CLINICAL NEUROSCIENCE | 2012年 / 19卷 / 01期

关键词：

Glioma; Interstitial nephritis; Levetiracetam;

D O I：

10.1016/j.jocn.2011.08.007

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A 45-year-old man with a new diagnosis of low grade glioma was started on an escalating dose of levetiracetam (Lev) for seizure management. He gradually developed intractable nausea/vomiting and a high creatinine concentration due to acute renal failure which was attributed to Lev-induced interstitial nephritis. The medication was changed and his renal function rapidly improved to his baseline. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：177 / 178

页数：2

共 3 条

[1] Levetiracetam Induced Interstitial Nephritis and Renal Failure [J].

Hurwitz, Kathleen A. ;

Ingulli, Elizabeth G. ;

Krous, Henry F. .

PEDIATRIC NEUROLOGY, 2009, 41 (01) :57-58

[2] Tolerability and efficacy of oral loading of levetiracetam [J].

Koubeissi, M. Z. ;

Amina, S. ;

Pita, I. ;

Bergey, G. K. ;

Werz, M. A. .

NEUROLOGY, 2008, 70 (22) :2166-2170

[3] Pharmacokinetic profile of levetiracetam: toward ideal characteristics [J].

Patsalos, PN .

PHARMACOLOGY & THERAPEUTICS, 2000, 85 (02) :77-85

← 1 →